ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,054Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 680

$1.36M Total Retail Price of All Prescriptions

Rank: 33 out of 680

806 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 806 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

33% of this provider’s 806 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 11,568 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,579 551 S3 1 4
FUROSEMIDE 489 280 2 6
OMEPRAZOLE 449 264 3 7
AMLODIPINE BESYLATE 415 277 4 1
LEVOTHYROXINE SODIUM 411 267 5 2
TRAZODONE HCL 410 215 6 48
GABAPENTIN 381 186 7 15
LISINOPRIL 365 157 8 5
MELOXICAM 356 166 9 24
SIMVASTATIN 343 193 10 3
NEXIUM 343 131 10 16
CLONIDINE HCL 336 196 12 36
TRAMADOL HCL 297 176 13 18
GLYBURIDE-METFORMIN HCL 294 139 R 14 107
METOPROLOL TARTRATE 279 197 15 12
ATORVASTATIN CALCIUM 262 161 16 11
CARVEDILOL 256 160 17 23
METFORMIN HCL 256 101 17 8
CYCLOBENZAPRINE HCL 252 45 R 19 81
QUETIAPINE FUMARATE 244 140 20 64
AMITRIPTYLINE HCL 231 116 R 21 47
DIOVAN HCT 218 126 22 55
WARFARIN SODIUM 213 158 23 20
AZITHROMYCIN 207 89 24 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 206 97 25 37
ROPINIROLE HCL 200 108 26 99
ALLOPURINOL 196 161 27 33
GLIPIZIDE 187 120 28 63
LOVASTATIN 183 85 29 44
ESCITALOPRAM OXALATE 180 92 30 45
PAROXETINE HCL 179 71 31 76
LANTUS 179 94 31 49
PANTOPRAZOLE SODIUM 178 93 33 30
HYDROCHLOROTHIAZIDE 170 69 34 9
ZOLPIDEM TARTRATE 167 60 35 17
FLUOXETINE HCL 165 72 36 74
BENICAR HCT 157 92 37 150
PREDNISONE 156 69 38 50
FLUTICASONE PROPIONATE 149 92 39 41
ADVAIR DISKUS 146 86 40 53
PRAVASTATIN SODIUM 145 72 41 10
NAMENDA 145 141 41 35
CARISOPRODOL 139 0 R 43 83
LYRICA 137 41 44 77
SPIRIVA 137 63 44 70
POTASSIUM CHLORIDE 137 64 44 14
LACTULOSE 135 81 47 92
SERTRALINE HCL 134 83 48 28
POLYETHYLENE GLYCOL 3350 128 90 49 62
RISPERIDONE 126 67 50 80
NAPROXEN 126 23 50 121
TAMSULOSIN HCL 119 99 52 34
CRESTOR 119 48 52 25
SINGULAIR 116 32 54 91
OLANZAPINE 115 66 55 116
JANUVIA 110 75 56 60
CLOPIDOGREL 110 48 56 26
CIPROFLOXACIN HCL 109 69 58 57
DONEPEZIL HCL 107 88 59 27
IBUPROFEN 105 17 60 126
METOPROLOL SUCCINATE 103 45 61 13
DIVALPROEX SODIUM 100 51 62 110
MEGESTROL ACETATE 99 76 R 63 88
NOVOLIN R 94 67 64 113
LIPITOR 92 64 65 68
CYMBALTA 92 38 65 46
SEROQUEL 90 51 67 123
AGGRENOX 90 63 67 177
CITALOPRAM HBR 90 58 67 22
PLAVIX 87 49 70 39
ALBUTEROL SULFATE 85 63 71 154
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 40 72 94
DOXEPIN HCL 81 43 73 200
IPRATROPIUM BROMIDE 79 79 74 211
COLCRYS 78 61 75 166
LANTUS SOLOSTAR 76 33 76 84
MUPIROCIN 76 42 76 130
GLIPIZIDE XL 76 46 76 142
ATENOLOL 74 25 79 19
ISOSORBIDE MONONITRATE ER 74 51 79 59
DIGOXIN 74 46 79 58
PROAIR HFA 71 30 82 67
DEXILANT 70 36 83 171
LEVETIRACETAM 68 26 84 120
PREMARIN 67 20 R 85 105
SANTYL 67 55 85 170
BUMETANIDE 67 55 85 102
METHOTREXATE 66 13 88 314
DIOVAN 63 36 89 31
SPIRONOLACTONE 63 26 89 82
INSULIN SYRINGE 63 40 89 86
BACLOFEN 61 23 92 140
NASONEX 61 0 92 197
PROMETHAZINE HCL 59 17 R 94 96
NYSTATIN 58 46 95 191
DOXAZOSIN MESYLATE 56 38 96 73
ONGLYZA 55 34 97 136
NOVOLOG 55 36 97 167
BENICAR 53 40 99 131
MONTELUKAST SODIUM 52 23 100 157
HYDRALAZINE HCL 51 29 101 71
RANITIDINE HCL 50 27 102 56
BENZTROPINE MESYLATE 50 24 R 102 137
TIZANIDINE HCL 50 33 102 140
FENTANYL 50 31 S2 102 183
METOCLOPRAMIDE HCL 50 30 102 118
MECLIZINE HCL 50 24 102 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.